MXD3 and prostate adenocarcinoma: When all the results are taken into consideration, they indicate that MXD3 plays a significant role in the proliferation and stemness of PRAD, suggesting that it has the potential to be a therapeutic target for patients suffering from PRAD.[28] Wu et al revealed that practically all types of TCGA cancer have unregulated levels of MXD3 mRNA expression.